Pulmonx Corporation
LUNGNASDAQHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $77.72M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.13$2.89
- Volume (live)
- -
- Avg. volume (3M)
- 266.44K
Pulmonx (LUNG) Stock Price & Financial Analysis
Pulmonx Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.79 - $1.88 |
|---|---|
| 52-Week High | $2.89 |
| 52-Week Low | $1.13 |
| Open | $1.80 |
| Volume (last close) | 227.76K |
| Average Volume (3M) | 266.44K |
| Revenue (TTM) | 87.44M |
|---|---|
| Net Income (TTM) | -48.12M |
| Free Cash Flow (TTM) | -30.67M |
| EPS (TTM) | −$1.15 |
| Profit Margin | -55.03% |
| Operating Margin | -52.96% |
| Return on Equity (ROE) | -122.76% |
| Debt to Equity | 0.96 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 77.72M |
|---|---|
| Shares Outstanding | 42.47M |
| Price to Sales (P/S) | 0.89 |
| Price to Book (P/B) | 1.98 |
| EV/EBITDA | -1.41 |
| 50-Day MA | $2.05 |
|---|---|
| 200-Day MA | $1.65 |
| 1-Year Change | +18.24% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Pulmonx at a Glance
As of the Oct 23, 2026 close, Pulmonx (LUNG) has a market capitalization of $77.72M. The stock trades at 0.9× sales. Over the trailing twelve months it lost $48.12M on revenue of $87.44M and burned $30.67M of free cash flow. Revenue fell 3.4% year over year.
As of its latest reported balance sheet, it holds $55.84M in cash and securities against $37.53M of debt, a net cash position of $18.31M.
Pulmonx does not currently pay a dividend.
The share price is up 18.2% over the past year. At $1.83 (the Oct 23, 2026 close) it sits within its 52-week range of $1.13 to $2.89, above its 200-day moving average of $1.65.
Frequently Asked Questions About Pulmonx
What is the current stock price for LUNG?
As of the Oct 23, 2026 close, LUNG stock trades at $1.83. The 52-week range is $1.13–$2.89, with a day range of $1.79–$1.88.
What is the P/E ratio for LUNG?
The P/E ratio (Price-to-Earnings) for LUNG is shown in the Key Statistics section. This valuation metric helps compare Pulmonx Corporation to industry peers.
Does LUNG pay dividends?
Pulmonx does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LUNG?
Analyst ratings and recommendations for LUNG are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of LUNG?
As of the Oct 23, 2026 close, Pulmonx's market capitalization is $77.7M, classifying it as a micro-cap company. Pulmonx operates in the Healthcare sector within the Medical Devices industry.